Kraegen EW - Search Results

1

Alteration in phosphorylation of P20 is associated with insulin resistance.

Wang Y, Xu A, Ye J, Kraegen EW, Tse CA, Cooper GJ. Wang Y, et al. Among authors: kraegen ew. Diabetes. 2001 Aug;50(8):1821-7. doi: 10.2337/diabetes.50.8.1821. Diabetes. 2001. PMID: 11473044

2

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.

Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. Lee YS, et al. Among authors: kraegen ew. Diabetes. 2006 Aug;55(8):2256-64. doi: 10.2337/db06-0006. Diabetes. 2006. PMID: 16873688

3

Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.

Ye JM, Lim-Fraser M, Cooney GJ, Cooper GJ, Iglesias MA, Watson DG, Choong B, Kraegen EW. Ye JM, et al. Among authors: kraegen ew. Am J Physiol Endocrinol Metab. 2001 Apr;280(4):E562-9. doi: 10.1152/ajpendo.2001.280.4.E562. Am J Physiol Endocrinol Metab. 2001. PMID: 11254462 Free article.

4

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.

Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW. Ye JM, et al. Among authors: kraegen ew. Diabetes. 2001 Feb;50(2):411-7. doi: 10.2337/diabetes.50.2.411. Diabetes. 2001. PMID: 11272155

5

Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization.

Danaher RN, Loomes KM, Leonard BL, Whiting L, Hay DL, Xu LY, Kraegen EW, Phillips AR, Cooper GJ. Danaher RN, et al. Among authors: kraegen ew. Endocrinology. 2008 Jan;149(1):154-60. doi: 10.1210/en.2007-0583. Epub 2007 Oct 11. Endocrinology. 2008. PMID: 17932220

6

Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms.

Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM. Cleasby ME, et al. Among authors: kraegen ew. Diabetes. 2004 Dec;53(12):3258-66. doi: 10.2337/diabetes.53.12.3258. Diabetes. 2004. PMID: 15561958

7

Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.

Kraegen EW, Cooney GJ, Ye J, Thompson AL. Kraegen EW, et al. Exp Clin Endocrinol Diabetes. 2001;109(4):S516-26. doi: 10.1055/s-2001-15114. Exp Clin Endocrinol Diabetes. 2001. PMID: 11453039 Review.

8

The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.

Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. Kraegen EW, et al. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S189-201. doi: 10.1055/s-2001-18581. Exp Clin Endocrinol Diabetes. 2001. PMID: 11460570 Review.

9

AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.

Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW. Iglesias MA, et al. Among authors: kraegen ew. Diabetes. 2002 Oct;51(10):2886-94. doi: 10.2337/diabetes.51.10.2886. Diabetes. 2002. PMID: 12351423

10

AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.

Iglesias MA, Furler SM, Cooney GJ, Kraegen EW, Ye JM. Iglesias MA, et al. Among authors: kraegen ew. Diabetes. 2004 Jul;53(7):1649-54. doi: 10.2337/diabetes.53.7.1649. Diabetes. 2004. PMID: 15220186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters